IRCT20200823048491N1
Completed
Phase 3
Evaluation of the effect of N-acetylcysteine ??(NAC) in cardio-pulmonary pump device in preventing kidney failure in coronary heart surgery
ConditionsPatients undergoing open heart surgery.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Patients undergoing open heart surgery.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 40 to 65 years
- •GFR greater than 60
- •Creatinine less than 1\.5
- •Having conscious satisfaction
- •Patients with no previous history of open heart surgery
- •Patients undergoing CABG coronary artery bypass graft surgery
- •Patients who did not use ECMO and pump balloons before open heart surgery
Exclusion Criteria
- •Patients undergoing CABG without Cardiopulmonary pump (CPB)
- •Patients who had valve surgery in addition to CABG surgery
- •Patients who are candidates for emergency CABG
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effects of N-acetylcysteine administration in treatment of women with gestational diabetes mellitusGestational diabetes mellitus.Unspecified diabetes mellitus in pregnancy, childbirth and the puerperiumO24.9IRCT20170513033941N71Kashan University of Medical Sciences76
Completed
Phase 3
Study of the Effect of N-acetylcysteine on Urinary Tract Infection in Children.IRCT2013112015465N1Shahid Beheshti Medical University, Faculty of Pharmacy64
Completed
Phase 3
Evaluation the effect of N Acetyl Cystein (NAC) in myocardial infarctioIRCT20200519047506N1Karaj University of Medical Sciences142
Completed
Phase 3
The Evaluation of the Effect of N-acetylcysteine in Improving Methadone PoisoningPoisoning by Methadone.Poisoning by Methadone, undeterminedT40.3X4IRCT20210222050462N1Shahre-kord University of Medical Sciences64
Completed
Phase 3
The comparison of the effect of N-acetylcysteine and angiotensin- converting enzyme inhibitors with angiotensin-converting enzyme inhibitors alone to control blood pressure in hypertensive patientsBlood pressure.Essential (primary) hypertensionIRCT2014022616750N1Deputy of research and technology, Shahrekord university of medical sciences126